G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-02-17
DOI
10.3389/fphar.2015.00024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: An in vitro study
- (2014) Soha Namazi et al. BIOMEDICINE & PHARMACOTHERAPY
- Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts
- (2014) Chris R Cardwell et al. BMC Medicine
- Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
- (2014) Akanksha Thakur et al. JOURNAL OF CARDIAC FAILURE
- EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial
- (2014) Andrew S C Rice et al. LANCET
- Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells
- (2014) Soha Namazi et al. TUMOR BIOLOGY
- Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury
- (2013) Gerry T. M. Wagenaar et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy
- (2013) Huyen Pham et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response
- (2013) P. Sánchez-Rovira et al. Clinical & Translational Oncology
- Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
- (2013) Gitte Vrelits Sørensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
- (2013) Young Kwang Chae et al. Journal of Cancer
- Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years
- (2013) Christopher I. Li et al. JAMA Internal Medicine
- SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
- (2012) Jorma J. de Ronde et al. BREAST CANCER RESEARCH AND TREATMENT
- Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways
- (2012) Ahmed Z El-Hashim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
- (2012) Xuesong Chen et al. CANCER LETTERS
- Intratracheal Administration of a Nanoparticle-Based Therapy with the Angiotensin II Type 2 Receptor Gene Attenuates Lung Cancer Growth
- (2012) A. Kawabata et al. CANCER RESEARCH
- Angiotensin-(1–7): beyond the cardio-renal actions
- (2012) Danielle G. Passos-Silva et al. CLINICAL SCIENCE
- Update on the Angiotensin AT2 Receptor
- (2012) Claudia A. McCarthy et al. CURRENT HYPERTENSION REPORTS
- Recent advances involving the renin–angiotensin system
- (2012) Steven D. Crowley et al. EXPERIMENTAL CELL RESEARCH
- Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review
- (2012) Anderson J Ferreira et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Possible Involvement of Angiotensin-Converting Enzyme 2 and Mas Activation in Inhibitory Effects of Angiotensin II Type 1 Receptor Blockade on Vascular Remodeling
- (2012) Masaru Iwai et al. HYPERTENSION
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- New therapeutic pathways in the RAS
- (2012) Michael Bader et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
- (2012) Sylvie Rodrigues-Ferreira et al. PLoS One
- Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer
- (2012) Laurent Azoulay et al. PLoS One
- Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis
- (2012) Bhavani Krishnan et al. PROSTATE
- Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1
- (2012) Bhavani Krishnan et al. PROSTATE
- Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database
- (2012) K. Bhaskaran et al. BMJ-British Medical Journal
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
- (2011) Úna C. Mc Menamin et al. CANCER CAUSES & CONTROL
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma
- (2011) Xueqiang Ding et al. Molecular Oncology
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
- (2010) Chiyo Doi et al. BMC CANCER
- Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
- (2010) Christopher Lobo et al. BREAST CANCER RESEARCH AND TREATMENT
- Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
- (2010) Lara Pickel et al. CANCER BIOLOGY & THERAPY
- Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
- (2010) Eleanor I Ager et al. Cancer Cell International
- Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors
- (2010) K. L. Cook et al. CANCER RESEARCH
- Non-peptide AT2-receptor agonists
- (2010) U Muscha Steckelings et al. CURRENT OPINION IN PHARMACOLOGY
- Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
- (2010) Nicolas Clere et al. INTERNATIONAL JOURNAL OF CANCER
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone
- (2009) W. J. Petty et al. CLINICAL CANCER RESEARCH
- The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor
- (2009) Enzo et al. Frontiers in Bioscience-Landmark
- Angiotensin inhibition and malignancies: a review
- (2009) T Rosenthal et al. JOURNAL OF HUMAN HYPERTENSION
- Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential
- (2009) Thomas Unger et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor
- (2009) D. R. Soto-Pantoja et al. MOLECULAR CANCER THERAPEUTICS
- 8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis
- (2009) Sylvie Rodrigues-Ferreira et al. PLoS One
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
- (2008) O Arrieta et al. BRITISH JOURNAL OF CANCER
- Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
- (2008) D. Herr et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search